soul trial oral semaglutide cardiovascular outcomes soul trial results Frontiers soul trial oral semaglutide cardiovascular

Es un contenido educativo y no reemplaza la atencin mdica personalizada

Lean proteins, vegetables, and complex carbohydrates are much better tolerated

Sleeping adequately

The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)

Ivy had been on a rollercoaster of diets for decadesthe kind of journey where you pack your bags with hope, only to end up stranded in a desert of disappointment

Some other areas the researchers found semaglutide to be beneficial in compared to sitagliptin include dementia, depression, and ischemic stroke